9 Results

People

  1. Giralt
    Giralt
  2. Jakubowski
    Jakubowski
  3. Perales
    Perales
  4. Stein
    Stein
  5. Tallman
    Tallman
  6. Gyurkocza
    Gyurkocza
  7. Tamari
    Tamari
  8. Ponce
    Ponce
  9. Shaffer
    Shaffer
  10. Cho
    Cho

Groups

  1. Adult Leukemia (9)
  2. Bone Marrow Transplant (9)
  3. Center for Hematologic Malignancies (9)
  4. Department of Medicine (9)
  5. Hematologic Malignancies, Division of (9)
  6. Survivorship Research (9)
  7. Biostatistics Service (7)
  8. CTCR Scholars (7)
  9. Epidemiology and Biostatistics (7)
  10. MSK Grad Students (7)
  1. "Hematologic Malignancies, Division of"
  2. "Bone Marrow Transplant"
  3. "Ann Jakubowski"
  4. "Department of Medicine"
  5. "Center for Hematologic Malignancies"
  6. "Eytan Stein"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Adult Leukemia (9)
  2. Bone Marrow Transplant (9)
  3. Center for Hematologic Malignancies (9)
  4. Department of Medicine (9)
  5. Hematologic Malignancies, Division of (9)
  6. Survivorship Research (9)

More Groups

People
  1. Ann Jakubowski (9)
  2. Eytan Stein (9)
  3. Miguel-Angel Perales (9)
  4. Sergio Giralt (9)
  5. Brian Shaffer (8)
  6. Martin Tallman (8)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (1)
  6. 2018 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (4)
  2. Blood (2)
  3. American Journal of Hematology (1)
  4. Leukemia and Lymphoma (1)
  5. Transplantation and Cellular Therapy (1)
Publishers
  1. Elsevier Inc. (5)
  2. American Society of Hematology (2)
  3. John Wiley & Sons (1)
  4. Taylor & Francis Group (1)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia
    Journal Article

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
    Journal Article

    Zuanelli Brambilla, C.; Lobaugh, S. M.; Ruiz, J. D.; Dahi, P. B.; Goldberg, A. D.; Young, J. W.; Gyurkocza, B.; Shaffer, B. C.; Ponce, D. M.; Tamari, R.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy
    Meeting Abstract

    Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Preston, E. V.; Chinapen, S.; Borrill, T.; Davis, E.; Shaffer, B. C.; Tamari, R.; Jakubowski, A. A.; Perales, M. A.; Ponce, D. M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning is associated with favorable outcomes in mixed phenotype acute leukemia
    Journal Article

    Getta, B. M.; Roshal, M.; Zheng, J.; Park, J. H.; Stein, E. M.; Levine, R.; Papadopoulos, E. B.; Jakubowski, A. A.; Kernan, N. A.; Steinherz, P.; more...
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Do patients with high risk or relapsed core binding factor acute myeloid leukemia benefit from salvage allogeneic stem cell transplantation?
    Meeting Abstract

    Hobbs, G.; Kishtagari, A.; Hilden, P.; Barker, J. N.; Jakubowski, A. A.; Papadopoulos, E.; Devlin, S.; Boulad, F.; Kernan, N.; Kobos, R.; more...
    Biology of Blood and Marrow Transplantation (2014)

    Fulltext@MSK | Save